Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

K2M Group Holdings: Takes A Tumble On Lower Than Expected Q4 Numbers

Published 03/07/2017, 08:13 AM
Updated 05/14/2017, 06:45 AM

K2M Group H (NASDAQ:KTWO)

K2M Group Holdings, Inc. (KTWO), a medical device company yesterday reported their fourth quarter and full year 2016 financial results. K2M reported fourth quarter earnings of a loss of $0.30 per share which fell short of analyst expectations of a loss of $0.26 per share. K2M reported fourth quarter revenues of $61.8 million.

K2M Group Holdings, Inc. CEO’s Comments

“We reported constant currency revenue growth of 14.9% year-over-year in the fourth quarter, driven by U.S. constant currency revenue growth of 21.5% year-over-year,” said President and Chief Executive Officer, Eric Major. “We delivered approximately 17% growth in the U.S. in calendar year 2016 and we believe this strong performance reflects the Company’s success in executing our strategic plan to introduce differentiated spine technologies and expand our global distribution network. Our U.S. growth reflects the clearest indication yet of the increasing adoption of our innovative products by the spine surgeon community. Outside the U.S., we successfully navigated challenging market disruptions with our distributors in Australia and Japan earlier in 2016, and look forward to building on our improving results during 2017 without the expectation of these headwinds. We continue to anticipate our ability to grow our U.S. revenue in the mid-teens in 2017 with improved profitability.” Globe Newswire

KTWO Technical Analysis

KTWO Technical Analysis

KTWO opened trading yesterday at $21.50 which was down from the previous day’s trading close of $21.54. Shares closed trading yesterday at $21.30 and spiked down after market to $19.60, equivalent to a 8% decrease from the closing price. Taking a look at the daily chart we can see that the last time KTWO traded below these levels we have to go all the way back to December 1st 2016, when it traded at $19.03.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Taking a closer look at the daily chart we can see that before the spike down KTWO had been in an overall upward trend dating back to October 27th, 2016 when it traded at $16.39. KTWO has a float of 21.39 million shares and traded 1.71 times the normal daily trading volume on Monday.

For trading purposes, I would like to see KTWO open trading on Tuesday below $20.15 and if it does I would be looking to take a short position at the bell. My stop loss would be $0.20 from my entry position fearing anything more than that and the stock would start to fill in the gap down.

Company Profile

K2M Group Holdings, Inc., a medical device company, focuses on designing, developing, and commercializing proprietary complex spine technologies and techniques in the United States and internationally. It provides implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor.

The company’s complex spine products comprise MESA and MESA 2 deformity spinal, EVEREST deformity spinal, MESA rail deformity spinal, Cricket deformity, Quicket deformity, CAPRI corpectomy cage, DENALI deformity spinal, MESA small stature spinal, MESA rail small stature spinal, MESA mini spinal, SERENGETI complex spine minimally invasive retractor, RAVINE complex spine lateral access, and SANTORINI corpectomy cage systems, as well as NILE alternative fixation technology.

Its minimally invasive spine products consist of SERENGETI minimally invasive retractor, RAVINE lateral access, CASCADIA lateral interbody, ALEUTIAN lateral interbody, TERRA NOVA minimally invasive access, EVEREST minimally invasive spinal and XT spinal systems. In addition, the company’s degenerative spine products consist of EVEREST degenerative spinal, CASCADIA AN and TL interbody, ALEUTIAN interbody, RHINE cervical disc, CHESAPEAKE interbody, PYRENEES cervical plate, and BLUE RIDGE hybrid cervical plate systems, as well as BaseCamp rod reduction technology. It markets its products under the ALEUTIAN, Basecamp, BLUE RIDGE, CAPRI, CASCADIA, CASPIAN, CAYMAN, CHESAPEAKE, Deformity Cricket, DENALI, EVEREST, Lamellar Titanium Technology, MESA, NILE, PYRENEES, Quicket, Rail 4D Technology, RAVINE, RHINE, SANTORINI, SERENGETI, TERRA NOVA, and tifix names.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company promotes, markets, and sells its products through direct sales employees independent agencies, and distributor partners. K2M Group Holdings, Inc. was founded in 2004 and is headquartered in Leesburg, Virginia.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.